News
Sensory Stimulation Systems, and GENUS, refer to a noninvasive procedure, i.e., a "digital therapeutic," being developed by Cognito Therapeutics. The company developed a wearable GammaSense ...
8 analysts have expressed a variety of opinions on Kymera Therapeutics KYMR over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...
9Bio Therapeutics co-founder, president, and chief scientific officer Philipe Gobeil envisions a future where fewer cancer patients need to choose between painful, toxic therapies that give them a ...
Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...
As May began, Repare Therapeutics announced an out-licensing agreement with the Canadian biotechnology firm DCx Biotherapeutics, involving certain discovery platforms and intellectual property/IP.
Nektar Therapeutics said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin on Tuesday. Shares climbed 27% to $12.15 in after-hours trading Monday ...
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing ...
Neurodegenerative diseases have always posed a significant therapeutic challenge due to the restrictive nature of the blood–brain barrier (BBB). Intranasal drug delivery has emerged as a noninvasive ...
Candid Therapeutics is a clinical-stage biotechnology company focused on transforming the treatment of autoimmune and inflammatory diseases through novel T-cell engager (TCE) platforms.
CRISPR Therapeutics ’ CRSP first marketed product is the one-shot gene therapy Casgevy, approved in late 2023 and early 2024 across the United States and Europe for two blood disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results